Hepatic and renal function markers were notably altered, with the encephalopathy group showing higher alanine aminotransferase (alanine aminotransferase: 178.67 ± 6.79 U/L vs 182.15 ± 8.53 U/L, P = .042), creatinine (1.21 ± 0.04 K/μL vs 1.23 ± 0.04 K/μL, P = .007), and bilirubin (0.54 ± 0.03 EU/dL vs 0.56 ± 0.04 EU/dL, P = .001). The gene discussed is GPT; the disease is Encephalopathy.